Bharat Biotech to boost Covaxin output to 700 mn doses per year

Bharat Biotech on Tuesday said it has scaled up its COVID-19 vaccine Covaxin manufacturing capacity to 700 million doses per annum. According to a press release issued by the city-based vaccine maker, manufacturing scale up has been carried out in a stepwise manner across multiple facilities at Hyderabad and Bangalore.
Sources said the company had 200 million doses capacity when it started producing Covaxin in the beginning. Capacity expansion in vaccines manufacturing is a long and tedious process, requiring investments and several years, the release said.